The first wave of coronavirus survivors are helping to fight COVID-19 by donating their antibody-rich plasma for clinical research trials in Canada and abroad. Susan Ormiston reports.
Listen to the full episode19:34
As scientists worldwide scramble for COVID-19 treatments and cures, some see promise in antibody-rich plasma of survivors. In Canada and beyond, survivors are donating their blood for new, fast-tracked, clinical trials.
Today, CBC senior correspondent Susan Ormiston joins us from Washington, D.C., to explain why antibody-rich plasma could be useful in the fight against the coronavirus.
Almost 18 million people have been reported to be infected by the novel coronavirus globally, and 685,000 have now died. Nearly 300,000 people were reported infected in the past 24 hours and 6400 dead. Here are the latest developments from around the world. Europe Ireland Ireland's chief medical officer on Saturday described a recent spike…